1991
DOI: 10.1084/jem.174.6.1399
|View full text |Cite
|
Sign up to set email alerts
|

Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.

Abstract: SummaryDecay-accelerating factor (DAF) is a 70-kD membrane glycoprotein that prevents complement (C)-mediated hemolysis by blocking the assembly or accelerating the decay of C3 convertase. Purified DAF is known to incorporate into the membrane of DAF-deficient cells, inhibiting lysis. Since Schistosoma mansoni is a blood-dweUing parasite, we investigated whether DAF can be transferred from human erythrocytes to the worm and protect it against C-mediated killing in vitro. We have found that schistosomula (schla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
16
0

Year Published

1993
1993
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(17 citation statements)
references
References 46 publications
(40 reference statements)
1
16
0
Order By: Relevance
“…Previous studies have investigated the interaction between schistosomes and complement and have described several mechanisms that schistosomes have developed to evade complement-mediated lysis (12)(13)(14)(15)(16)(17)(18). Consistent with these studies, we found that infected C3-deficient mice had a similar adult worm burden to that of infected wild-type (WT) mice, supporting the finding that C3 is not involved in controlling worm development or establishment (Table I).…”
Section: The Absence Of C3 Does Not Alter Schistosome Burden or Liversupporting
confidence: 80%
See 1 more Smart Citation
“…Previous studies have investigated the interaction between schistosomes and complement and have described several mechanisms that schistosomes have developed to evade complement-mediated lysis (12)(13)(14)(15)(16)(17)(18). Consistent with these studies, we found that infected C3-deficient mice had a similar adult worm burden to that of infected wild-type (WT) mice, supporting the finding that C3 is not involved in controlling worm development or establishment (Table I).…”
Section: The Absence Of C3 Does Not Alter Schistosome Burden or Liversupporting
confidence: 80%
“…C3 and its derivatives have also been shown to be important in Ab responses when the Ag dose is limiting (6, 7), clearance of Ag-Ab complexes (8), inhibition of IL-12 production by macrophages (9), and germinal center formation (10,11). Although previous studies have shown that schistosomes have developed several mechanisms to evade complement-mediated lysis by the host (12)(13)(14)(15)(16)(17)(18), the possible contribution of C3 to response development during schistosome infection has not been investigated.…”
mentioning
confidence: 99%
“…One of the most striking immunoevasive mechanisms displayed by these parasites is the acquisition of host products onto the tegument of the schistosome to mask its foreign status. Host molecules adsorbed onto the surface include immunoglobulins (20,40,44), major histocompatibility complex products (3,36), ␤ 2 -microglobulin (␤ 2 m) (40), complement components (35,38), ␣ 2 -macroglobulin (7,19), C3 decay-accelerating factor (14), and glycolipids in the form of A, B, H, and Lewis blood group antigens (12).…”
mentioning
confidence: 99%
“…This concept of molecular mimicry was introduced by Yoshino and Bayne (1983) when they found haemolymph-like antigens on the surface tegument of sporocysts. Similar mimicry has been suggested in schistosomula by Guillou et al (2007) and Horta and Ramalho-Pinto (1991) by demonstrating that decay-accelerating factor from human erythrocytes could be transferred to S. mansoni and protect it against complement-mediated haemolysis. We observed that the secondary sporocysts were recognised at a lower rate than the primary sporocysts in the in vitro experiments.…”
Section: Discussionmentioning
confidence: 73%